Nauru vs Puerto Rico: The number of people with susceptibility test result for rifampicin
Nauru
14
in 2021
Puerto Rico
14
in 2021
Nauru rank
136th
Puerto Rico rank
136th
The number of people with susceptibility test result for rifampicin over time
- Nauru
- Puerto Rico
How they compare
Nauru currently reports 14 against 14 in Puerto Rico, a difference of 0.
Across all 5 years both countries report, Puerto Rico has been ahead every year.
Nauru ranks 136th and Puerto Rico ranks 136th of 155 countries.
Puerto Rico has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nauru | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0 | 25.33 | 25.33 | Puerto Rico |
| 2020s | 7 | 18 | 11 | Puerto Rico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Nauru or Puerto Rico?
- Nauru, at 14 against 14 in Puerto Rico as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Nauru and Puerto Rico?
- 0, with Nauru ahead.
- How many years of comparable data are there for Nauru and Puerto Rico?
- 5 years are reported by both, from 2017 to 2021.
- How do Nauru and Puerto Rico rank globally for the number of people with susceptibility test result for rifampicin?
- Nauru ranks 136th and Puerto Rico ranks 136th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.